Table 1.

HIV prevalence^a, care^b, and viral suppression^b among persons aged at least 13 years, 2016, by selected characteristics, United States

	Persons living with diagnosed infection		Persons with at least one CD4 or viral load tests Among persons with diagnosed infection	Viral load less than 200 copies/ml Among persons with at least one CD4 or viral load tests
	(%)	(95% CI)	(%)	(%)
Sex
Male	84.8	(83.2–86.6)	74.2	83.7
Female	88.8	(86.0–91.9)	74.0	80.3
Age at year-end 2015 (year)
13–24	56.0	(54.1–58.0)	76.3	70.5
25–34	70.9	(69.9–71.8)	74.1	76.4
35–44	84.6	(83.8–85.5)	73.2	80.7
45–54	91.8	(91.2–92.5)	75.3	84.7
≥55	94.2	(93.4–95.0)	73.2	87.7
Race/ethnicity
American Indian/Alaska Native	81.6	(60.9–100.0)	73.4	81.3
Asian	80.9	(70.5–94.8)	73.5	90.6
Black/African American	85.2	(82.9–87.6)	71.7	78.3
Hispanic/Latino	83.3	(80.2–86.5)	71.9	85.3
Native Hawaiian/other Pacific Islander	82.4	(51.6–100.0)	71.4	88.8
White	88.5	(85.9–91.3)	77.8	87.2
Multiple races	86.4	(80.2–93.5)	85.9	81.3
Transmission category
Male-to-male sexual contact	83.6	(81.7–85.6)	75.8	85.0
Injection drug use	94.0	(89.7–98.8)
Male	93.5	(87.7–100.0)	63.6	80.6
Female	94.7	(88.6–100.0)	72.5	78.7
Male-to-male sexual contact and injection drug use	92.3	(86.5–99.0)	78.4	79.4
Heterosexual contact	85.5	(82.7–88.4)
Male	81.6	(76.4–87.5)	69.6	81.7
Female	87.3	(84.2–90.6)	74.3	81.2
Total	85.8	(84.3–87.3)	74.2	82.9

Data from Centers for Disease Control and Prevention [10^■,20^■]. CD4, CD4+ T-lymphocyte count (cells/μl) or percentage; VL, viral load (copies/ml).

^aEstimated based on the first CD4 test result after diagnosis and a CD4 depletion model.

^bOn the basis of data from 41 states and Washington, DC.